RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Losartan Lacks Benefit in Inherited HCM
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 52
SP 18
OP 19
DO 10.1177/155989771452010
UL http://mdc.sagepub.com/content/14/52/18.abstract
AB Hypertrophic cardiomyopathy (HCM) has a prevalence of 1 in every 500 individuals, making it the most frequently inherited cardiomyopathy, and it results in the fibrosis and hypertrophy of the left ventricle. This article discusses data from the Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy [INHERIT; NCT01447654] trial, which investigated the use of losartan for HCM.